Cargando…
RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
Tamoxifen (TAM) resistance remains a major obstacle in the treatment of advanced breast cancer (BCa). In addition to the competitive inhibition of the estrogen receptor (ER) signaling pathway, damping of mitochondrial function by increasing reactive oxygen species (ROS) is critical for enhancing TAM...
Autores principales: | Xu, Zhi, Wang, Xiumei, Sun, Wenbo, Xu, Fan, Kou, Hengyuan, Hu, Weizi, Zhang, Yanyan, Jiang, Qin, Tang, Jinhai, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641764/ https://www.ncbi.nlm.nih.gov/pubmed/37944384 http://dx.doi.org/10.1016/j.redox.2023.102952 |
Ejemplares similares
-
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
por: Zhang, Yanyan, et al.
Publicado: (2022) -
RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression
por: Wang, Mei, et al.
Publicado: (2020) -
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
por: Zhang, Yanyan, et al.
Publicado: (2018) -
RelB and Neuroinflammation
por: Mockenhaupt, Karli, et al.
Publicado: (2021) -
RelB and RelE of Escherichia coli Form a Tight Complex That Represses Transcription via the Ribbon–Helix–Helix Motif in RelB
por: Overgaard, Martin, et al.
Publicado: (2009)